Poster Abstract Session:
226. Clinical Practice Issues: OPAT
Saturday, October 6, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Pediatric ID, Adult ID

Health-related Social Vulnerabilities in a Pediatric Outpatient Antimicrobial Therapy (OPAT) Program
Kimberly Felder, PA-C, MCR; Natalie Koskela, BS; Raul Vega-Juarez, BS candidate; Mauricio Gomez, BS candidate; Jared Austin, MD; David Wagner, PhD; Michael Harris, PhD; Katharine Zuckerman, MD, MPH; Louise Vaz, MD, MPH
  • IDWeek 2018 Poster_3 LEV.pdf (1.1 MB)
  • Healthcare Utilization in Older versus Younger Adults on Outpatient Parenteral Antimicrobial Therapy According to Discharge Location
    Rupak Datta, MD PhD; Kaylen Brzozowski, BS; Joseph Canterino, MD; Maricar Malinis, MD, FACP, FIDSA; Vincent Quagliarello, MD, FIDSA; Manisha Juthani-Mehta, MD, FIDSA, FSHEA
    Economic Evaluation of Outpatient Parenteral Antimicrobial Therapy in Children
    Nathan Krah, PhD; Lawanda Esquibel, BS; Tyler Bardsley, MS; Richard E. Nelson, PhD; Andrew Pavia, MD, FIDSA, FSHEA, FPIDS; Adam L. Hersh, MD, PhD
    Who Really Benefits Financially From OPAT: Patients/Families Or Healthcare Institutions?
    Laila Ibrahim, MBBChBAO; Li Huang, PhD; Sandy Hopper, MBBS; Kim Dalziel, PhD; Franz Babl, MD; Penelope Bryant, BM BCh, PhD
    Outpatient Parenteral Antimicrobial Therapy in Nonagenarians
    Caitlin Blaskewicz, DO, PhD; Steven Gordon, MD; Susan J. Rehm, MD, FIDSA; Angela Everett, AAS; Nabin Shrestha, MD, MPH, FIDSA, FSHEA
    Implementation of IV Push Antibiotics for OPAT in a Safety Net Hospital Following a National Fluid Shortage
    Kavita Bhavan, MD, MHS; Cylaina Bird, BA; Anisha Ganguly, B.S., B.A.; Helen King, MD; Aurelia Schmalstieg, MD; Norman Mang, PharmD; Jessica Ortwine, PharmD; Wenjing Wei, PharmD; Ryan Collins, PA
  • New IV push poster final.pdf (356.6 kB)
  • A Dedicated OPAT Program Reduces Readmission and Complications Rates
    Wesley Willeford, MD; J. Andrew Carr, Pharm.D., BCPS (AQ-ID); Rachael A. Lee, MD; Mukesh Patel, MD; Sonya Heath, MD; John W. Baddley, MD; Todd P McCarty, MD
    Sustained Reduction in 30 day Readmission Rates after Implementation of an OPAT Program in an Academic Medical Center
    Kathleen Sheridan, DO; Maighdlin Anderson, DNP; Joshua Wingfield, DNP; Lauren McKibben, PharmD
  • OPAT Poster IDSA 2018.pdf (262.5 kB)
  • Posters
  • Poster.pdf (141.5 kB)
  • Patients with Prosthetic Joint Infections Receiving Outpatient Parenteral Antimicrobial Therapy: Characteristics and Readmission Rates
    Sara Gore, MD; Fizza Gillani, PhD; Erika M D'Agata, MD, MPH; Jennifer Adelson-Mitty, MD, MPH; Curt Beckwith, MD
  • OPAT PJI_IDWeek Poster.pdf (845.3 kB)
  • Heterogeneous Hospitalization Outcomes of People Who Use Drugs: The Type of Drug(s) Used Matters
    Elisabeth Merchant, MD; Deirdre Burke, MPH; Chanelle Diaz, MD; Joshua Barocas, MD; Hansel Tookes III, MD, MPH; Alysse Wurcel, MD, MS
  • IDWeek Poster Merchant.pdf (416.9 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.